Residency · Cincinnati, OH
Sponsored by University of Cincinnati Medical Center Inc.
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
The New England journal of medicine · 2023 · 156 citations · Alan Fleischer
United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.
Journal of the American Academy of Dermatology · 2021 · 208 citations · Pushkar Aggarwal, Alan Fleischer
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 169 citations · Henry Quach
Cutaneous adverse events caused by immune checkpoint inhibitors.
Journal of the American Academy of Dermatology · 2021 · 114 citations · Henry Quach
Laryngotracheal stenosis: Mechanistic review.
Head & neck · 2022 · 49 citations · Ariel Finberg
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial.
Lancet (London, England) · 2025 · 21 citations ·
A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
Orphanet journal of rare diseases · 2021 · 82 citations · Emily Gorell
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology.
American journal of clinical dermatology · 2023 · 24 citations · Aaron Secrest